Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial.

Grady D, Sawaya GF, Johnson KC, Koltun W, Hess R, Vittinghoff E, Kristof M, Tagliaferri M, Cohen I, Ensrud KE.

Menopause. 2009 May-Jun;16(3):458-65. doi: 10.1097/gme.0b013e31818e64dd.

PMID:
19182698
2.

Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.

Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.

Am J Obstet Gynecol. 2004 Dec;191(6):1979-88.

PMID:
15592280
4.

Clinically meaningful efficacy of a non-estrogen agent: re-analysis of phase-2 data evaluating MF101.

Tagliaferri M, Creasman J, Caygill KA, Olyaie A, Leitman D, Cohen I, Grady D.

Climacteric. 2012 Dec;15(6):607-10. doi: 10.3109/13697137.2011.630113. Epub 2012 Jan 18.

PMID:
22257013
5.

A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women.

Haines CJ, Lam PM, Chung TK, Cheng KF, Leung PC.

Climacteric. 2008 Jun;11(3):244-51. doi: 10.1080/13697130802073029.

PMID:
18568789
6.

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.

Speroff L, Gass M, Constantine G, Olivier S; Study 315 Investigators.

Obstet Gynecol. 2008 Jan;111(1):77-87. doi: 10.1097/01.AOG.0000297371.89129.b3.

PMID:
18165395
7.

Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.

Pickar JH, Mirkin S.

Menopause Int. 2010 Sep;16(3):121-8. doi: 10.1258/mi.2010.010033. Review.

PMID:
20956688
8.
9.

Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.

Palacios S, Farias ML, Luebbert H, Gomez G, Yabur JA, Quail DC, Turbi C, Kayath MJ, Almeida MJ, Mönnig E, Nickelsen T.

Am J Obstet Gynecol. 2004 Jul;191(1):121-31.

PMID:
15295352
10.
12.

Initial 17beta-estradiol dose for treating vasomotor symptoms.

Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J.

Obstet Gynecol. 2000 May;95(5):726-31.

PMID:
10775738
13.

Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.

Lobo RA, Pinkerton JV, Gass ML, Dorin MH, Ronkin S, Pickar JH, Constantine G.

Fertil Steril. 2009 Sep;92(3):1025-38. doi: 10.1016/j.fertnstert.2009.03.113. Epub 2009 Jul 26.

PMID:
19635615
14.

Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.

Utian W, Yu H, Bobula J, Mirkin S, Olivier S, Pickar JH.

Maturitas. 2009 Aug 20;63(4):329-35. doi: 10.1016/j.maturitas.2009.06.006. Epub 2009 Jul 31.

PMID:
19647382
15.

Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial.

Valiati B, Capp E, Edelweiss MI, de Freitas FM, Wender MC.

Maturitas. 2009 Jan 20;62(1):81-4. doi: 10.1016/j.maturitas.2008.10.013. Epub 2008 Dec 20.

PMID:
19097715
16.

Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.

Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA.

Menopause. 2000 Jul-Aug;7(4):236-42. Erratum in: Menopause 2000 Nov-Dec;7(6):422.

PMID:
10914616
17.
18.

MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.

Leitman DC, Christians U.

Expert Opin Investig Drugs. 2012 Jul;21(7):1031-42. doi: 10.1517/13543784.2012.685652. Epub 2012 May 23. Review.

PMID:
22616988
19.

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial.

Grady D, Cohen B, Tice J, Kristof M, Olyaie A, Sawaya GF.

Obstet Gynecol. 2007 Apr;109(4):823-30.

PMID:
17400842
20.

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.

D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.

Menopause. 2009 Mar-Apr;16(2):301-6. doi: 10.1097/gme.0b013e318186d7e2.

PMID:
19034051
Items per page

Supplemental Content

Write to the Help Desk